Summary
Johnson & Johnson (JNJ) has filed an 8-K report on February 13, 2020, disclosing a significant governance change proposed by its Board of Directors. The Board unanimously voted to recommend that shareholders approve an amendment to the company's Restated Certificate of Incorporation. This amendment aims to remove the provision that currently requires shareholders to have "cause" to remove a director. If approved, this change will allow for the removal of directors by a simple majority vote of shareholders, without the need to prove cause. This proposed amendment represents a shift towards greater shareholder power in director accountability. The detailed proposal will be included in the company's 2020 proxy statement. Should shareholders approve this change, the Board will then implement conforming amendments to the company's By-Laws. Investors should monitor the 2020 Annual Shareholder Meeting for the vote on this proposal, as it could impact board composition and governance dynamics.
Key Highlights
- 1Johnson & Johnson's Board of Directors has unanimously approved a proposal to amend the company's Restated Certificate of Incorporation.
- 2The proposed amendment seeks to eliminate the requirement for 'cause' when shareholders remove a director.
- 3This change would allow for the removal of directors by a shareholder vote without needing to establish cause.
- 4The proposal will be submitted to shareholders for approval at the 2020 Annual Shareholder Meeting.
- 5If approved, a conforming amendment to the company's By-Laws will also be made.
- 6The full details of the proposed amendment will be provided in the company's 2020 proxy statement.